Skip to main content
Journal ArticleOPEN ACCESS

Vedolizumab for induction and maintenance of remission in Crohn’s disease

Cochrane Database of Systematic Reviews (2020) 2020(5)
DOI: 10.1002/14651858.CD013611
1Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The primary objective of this systematic review of the literature is to assess the efficacy and safety of vedolizumab in the induction and maintenance of remission in Crohn's disease.

Cite

CITATION STYLE

APA

Hui, S., Krishna, A., Ding, N. S., & Boyapati, R. K. (2020). Vedolizumab for induction and maintenance of remission in Crohn’s disease. Cochrane Database of Systematic Reviews, 2020(5). https://doi.org/10.1002/14651858.CD013611

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free